Literature DB >> 11605788

Ambulatory blood pressure monitoring after recovery from hemolytic uremic syndrome.

R T Krmar1, J R Ferraris, J A Ramirez, S Ruiz, A Salomon, H M Galvez, J J Janson, C R Galarza, G Waisman.   

Abstract

The outcome of acute renal failure due to diarrhea-associated hemolytic uremic syndrome (D+ HUS) is generally predicted to be good. However, there are only a few long-term observations with detailed reports on long-term sequelae. Specifically, adequate long-term blood pressure (BP) evaluations are scarce. The present study evaluated BP in pediatric patients after childhood D+ HUS. The study group comprised 28 patients (20 males) aged 6-23.5 years (median 10.1 years). All patients had a history of D+ HUS at a median age of 1.1 years (range 0.5-6 years). Based on the duration of oliguria and/or anuria, the primary disease was classified as mild (n=6), moderate (n=6), or severe (n=16). The BP in these patients was studied at a median time of 8.4 years (range 2.3-22.9 years) after manifestation of D+ HUS by means of office BP measurements and 24-h ambulatory BP monitoring (ABPM) using a Spacelabs 90207 oscillometric monitor. Measurements were compared with normal values of published standards for healthy children and adolescents. Conventional office BP measurements were above the 95th percentile in 1 patient. By ABPM, 2 patients were diagnosed to have mean systolic daytime and nighttime values in the hypertensive range, and systolic and diastolic hypertension was confirmed in the first patient. All these patients had a severe form of D+ HUS in the past. By applying ABPM, BP anomalies were detected in 5 additional patients. Elevated systolic BP loads were found in 4 patients, and daytime systolic and diastolic hypertension in the other 1. At the time of the study, 2 of them were classified as "recovered." The late outcome of D+ HUS may be worse than anticipated. BP anomalies as long-term sequelae of D+ HUS could be identified by ABPM but not by office BP measurements. These findings may represent an isolated sign of residual renal disturbance.

Entities:  

Mesh:

Year:  2001        PMID: 11605788     DOI: 10.1007/s004670100679

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome.

Authors:  Laura De Petris; Alessandra Gianviti; Ugo Giordano; Armando Calzolari; Alberto E Tozzi; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

Review 2.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

3.  Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.

Authors:  Catherine Monet-Didailler; Astrid Godron-Dubrasquet; Iona Madden; Yahsou Delmas; Brigitte Llanas; Jérôme Harambat
Journal:  Pediatr Nephrol       Date:  2018-10-27       Impact factor: 3.714

4.  Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database.

Authors:  Mamta Puraswani; Priyanka Khandelwal; Himanshi Saini; Savita Saini; Bahadur Singh Gurjar; Aditi Sinha; Rajashri Pramod Shende; Tushar Kanti Maiti; Abhishek Kumar Singh; Uma Kanga; Uma Ali; Indira Agarwal; Kanav Anand; Narayan Prasad; Padmaraj Rajendran; Rajiv Sinha; Anil Vasudevan; Anita Saxena; Sanjay Agarwal; Pankaj Hari; Arvind Sahu; Satyajit Rath; Arvind Bagga
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.